返回
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd（06990.HK）價格
06990.HK 股價走勢圖
SKB BIO-B (06990.HK)
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
HK$423.4
-2.44%
$-10.6
休市： Feb 13, 16:00:00 HKT
關鍵數據
前收市價
$438
開盤價
$434
當日範圍
$418.6 - $442.4
52週區間
$153.9 - $581
交易量
--
平均成交量
608.3K
每股盈餘 (TTM)
-3.61
股息收益率
--
市值
$68.1B
什麼是 SKB BIO-B？
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. engages in the research and development, manufacture, and commercialization of novel drugs. The company is headquartered in Chengdu, Sichuan and currently employs 1,870 full-time employees. The company went IPO on 2023-07-11. The firm is mainly engaged in the research and development, manufacturing and commercialization of novel drugs in oncology, immunology and other therapeutic areas. The firm's products are antibody drug conjugates (ADCs) SKB264, A166 and others. The firm's products are mainly used for the treatment of breast cancer, non-small cell lung cancer, gastrointestinal cancer and other diseases.
